BNTC compared with BHVN: revenue, margins and what each company keeps, and the suppliers and customers both name

BNTCBenitec Biopharma Inc.

Mkt capRevenueRevenue

BHVNBiohaven Ltd.

Mkt capRevenueRevenue

Compare

BNTCBenitec Biopharma Inc.

BHVNBiohaven Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BNTC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Sep 15 '26±33.9%▼−8.53%×0.25

Q3 FY26±46.8%▲+1.72%×0.04

Feb 12 '26±42.4%▼−2.66%×0.06

Nov 17 '25±33.2%▲+2.81%×0.08

BHVN

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±14.7%▼−6.49%×0.44

Q2 FY26±12.2%▼−0.34%×0.02

= impliedBNTC realized, solidBHVN realized, hatchedOne scale, both sides: full bar = 47%× = |realized| ÷ impliedSource: market data

May 5 '26

±13.2%

▼−4.24%

×0.32

Q1 FY26±17.6%▼−9.65%×0.55

BNTCBenitec Biopharma Inc.

8.77· pre 8.77· delayed

Mkt cap$304.9MRevenue$7,000Q4 FY23

BHVNBiohaven Ltd.

15.41· pre 15.44· delayed

Pre-marketOct 30 '26delayed

Mkt cap$2.3BRevenue—

Compare

Pre-marketOct 30 '26delayed

BNTCBenitec Biopharma Inc.

BHVNBiohaven Ltd.

8.77pre 8.77delayed

Price

15.41pre 15.44delayed

$304.9M

Mkt cap

$2.3B

Q4 FY23$7,000

Revenue

—

BNTC8.77vsBHVN15.41Pre-marketOct 30 '26delayed